Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,300 | 45,125 | 43,940 | 74,755 | 71,367 |
| Marketable Securities | 131,147 | 163,805 | 171,653 | 161,264 | 195,317 |
| Receivables | 1,912 | 4,037 | 2,525 | 2,110 | 2,180 |
| TOTAL | $202,687 | $219,585 | $227,889 | $245,206 | $276,809 |
| Non-Current Assets | |||||
| PPE Net | 13,136 | 13,291 | 13,919 | 13,929 | 14,314 |
| Investments And Advances | 5,244 | 20,081 | 46,446 | 59,103 | 65,704 |
| Other Non-Current Assets | 31,214 | 35,354 | 33,847 | 35,002 | 36,223 |
| TOTAL | $49,594 | $68,726 | $94,212 | $108,034 | $116,241 |
| Total Assets | $252,281 | $288,311 | $322,101 | $353,240 | $393,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,013 | 2,116 | 1,804 | 2,634 | 3,996 |
| Accrued Expenses | 12,098 | 14,953 | 12,025 | 9,053 | 14,171 |
| Other current liabilities | N/A | N/A | N/A | 7,430 | N/A |
| TOTAL | $26,541 | $35,495 | $41,983 | $40,212 | $49,788 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,590 | 10,578 | 20,517 | 21,095 | 24,394 |
| Other Non-Current Liabilities | 29,659 | 31,520 | 33,567 | 35,566 | 37,499 |
| TOTAL | $29,659 | $32,991 | $36,174 | $40,326 | $43,502 |
| Total Liabilities | $56,200 | $68,486 | $78,157 | $80,538 | $93,290 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,599 | 55,600 | 55,469 | 55,336 | 55,207 |
| Common Shares | 59 | 56 | 56 | 55 | 55 |
| Retained earnings | -445,905 | -418,479 | -390,587 | -357,205 | -326,184 |
| Other shareholders' equity | 32 | 7 | -221 | -199 | -407 |
| TOTAL | $196,081 | $219,825 | $243,944 | $272,702 | $299,760 |
| Total Liabilities And Equity | $252,281 | $288,311 | $322,101 | $353,240 | $393,050 |